Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 51.10
-3.40 (-6.24%)
At close: Mar 19, 2026
Qing Song Health Market Cap
Qing Song Health has a market cap or net worth of 3.38 billion as of March 20, 2026. Its market cap has decreased by -31.13% in one year.
Market Cap
3.38B
Enterprise Value
3.91B
Revenue
1.12B
Ranking
n/a
PE Ratio
36.76
Stock Price
51.10
Market Cap Chart
Since December 27, 2022, Qing Song Health's market cap has increased from 2.32B to 3.38B, an increase of 45.74%. That is a compound annual growth rate of 12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 3.38B | -18.76% |
| Dec 31, 2025 | 4.16B | -29.22% |
| Dec 31, 2024 | 5.88B | 28.33% |
| Dec 29, 2023 | 4.58B | 120.52% |
| Dec 30, 2022 | 2.08B | -10.44% |
| Dec 27, 2022 | 2.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 249.79B |
| Caliway Biopharmaceuticals | 180.15B |
| Bora Pharmaceuticals | 65.53B |
| Heron Neutron Medical | 65.33B |
| Onyx Healthcare | 3.77B |
| ACRO Biomedical | 3.76B |
| Nang Kuang Pharmaceutical | 3.69B |
| Genovate Biotechnology | 3.69B |